Literature DB >> 27983547

Factors associated with initial incomplete ablation for benign thyroid nodules after radiofrequency ablation: First results of CEUS evaluation.

Chong-Ke Zhao1,2,3, Hui-Xiong Xu1,2,3, Feng Lu1,2,3, Li-Ping Sun1,2,3, Ya-Ping He1,2,3, Le-Hang Guo1,2,3, Xiao-Long Li1,2,3, Xiao-Wan Bo1,2,3, Wen-Wen Yue1,2,3.   

Abstract

OBJECTIVE: To assess the factors associated with initial incomplete ablation (ICA) after radiofrequency ablation for benign thyroid nodules (BTNs).
MATERIALS AND METHODS: 69 BTNs (mean volume 6.35±5.66 ml, range 1.00-25.04 ml) confirmed by fine-needle aspiration cytology (FNAC) in fifty-four patients were treated with ultrasound-guided percutaneous radiofrequency ablation (RFA) and the local treatment efficacy was immediately assessed by intra-procedural contrast-enhanced ultrasound (CEUS). The RFA was performed with a bipolar electrode (CelonProSurge 150-T20, output power: 20 W). CEUS was performed with a second generation contrast agent under low acoustic power (i.e. coded phase inversion, CPI). Characteristics of clinical factors, findings on conventional gray-scale ultrasound, color-Doppler ultrasound, and CEUS were evaluated preoperatively. Factors associated with initial ICA and initial ICA patterns on CEUS were assessed. Volume reduction ratios (VRRs) of ICA nodules were compared with those with complete ablation (CA).
RESULTS: The RFA procedures were accomplished with a mean ablation time and mean total energy deposition of 11.13±3.39 min (range, 5.38-22.13 min) and 12612±4466 J (range, 6310-26130 J) respectively. CEUS detected initial ICA in 21 of 69 (30.8%) BTNs and 16 (76.2%) of the 21 BTNs with initial ICA achieved CA after additional RFA, leading to a final CA rate of 92.8% (64/69). The factors associated with initial ICA were predominantly solid nodule, nodule close to danger triangle area, nodule close to carotid artery, and peripheral blood flow on color-Doppler ultrasound (all P < 0.05). The mean VRRs of all BTNs were 23.4%, 54.4% and 81.9% at the 1-, 3- and 6-month follow-up, respectively. All BTNs achieved therapeutic success in this series in that all had VRRs of >50% at the 6-month follow-up, among which 7 nodules (10.1%) had VRRs of >90%. There were significant differences in VRRs between ICA nodules and CA nodules at the 3- and 6-month follow-up (all P < 0.05).
CONCLUSION: The factors associated with initial ICA after RFA for BTNs were predominantly solid nodules, nodule close to danger triangle area, nodule close to carotid artery, and peripheral blood flow on color-Doppler ultrasound. CEUS assists quick treatment response evaluation and facilitates subsequent additional RFA and final CA of the nodules. Nodules with CA achieve a better outcome in terms of VRR in comparison with those with ICA.

Entities:  

Keywords:  Radiofrequency ablation; contrast-enhanced ultrasound; incomplete ablation; thyroid; ultrasound

Mesh:

Substances:

Year:  2017        PMID: 27983547     DOI: 10.3233/CH-16208

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  17 in total

1.  2020 European Thyroid Association Clinical Practice Guideline for the Use of Image-Guided Ablation in Benign Thyroid Nodules.

Authors:  Enrico Papini; Hervé Monpeyssen; Andrea Frasoldati; Laszlo Hegedüs
Journal:  Eur Thyroid J       Date:  2020-06-08

2.  Radiofrequency Ablation for Benign Thyroid Nodules: 1-Year Follow-Up in 184 Patients.

Authors:  Nguyen Lam Vuong; Le Quang Dinh; Ho Tat Bang; Tran Thi Mai Thuy; Nguyen Hoang Bac; Tran Thanh Vy
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

3.  A New Perspective for Predicting the Therapeutic Success of RFA in Solid BTNs: Quantitative Initial RFA Ratio by Contrast-Enhanced Ultrasound.

Authors:  Yaqiong Zhu; Ziyu Jiao; Lianhua Zhu; Fang Xie; Qing Song; Lin Yan; Yukun Luo; Mingbo Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-14       Impact factor: 6.055

4.  Non-enhanced ultrasound is not a satisfactory modality for measuring necrotic ablated volume after radiofrequency ablation of benign thyroid nodules: a comparison with contrast-enhanced ultrasound.

Authors:  Lin Yan; Yukun Luo; Jing Xiao; Lin Lin
Journal:  Eur Radiol       Date:  2020-10-31       Impact factor: 5.315

5.  Radiofrequency ablation and thyroid nodules: updated systematic review.

Authors:  Haris Muhammad; Prasanna Santhanam; Jonathon O Russell
Journal:  Endocrine       Date:  2021-01-15       Impact factor: 3.633

Review 6.  Complications Following Radiofrequency Ablation of Benign Thyroid Nodules: A Systematic Review.

Authors:  Jin-Fen Wang; Tao Wu; Kun-Peng Hu; Wen Xu; Bo-Wen Zheng; Ge Tong; Zhi-Cheng Yao; Bo Liu; Jie Ren
Journal:  Chin Med J (Engl)       Date:  2017-06-05       Impact factor: 2.628

7.  Predictor Analysis in Radiofrequency Ablation of Benign Thyroid Nodules: A Single Center Experience.

Authors:  Alessandro Bisceglia; Ruth Rossetto; Sara Garberoglio; Angelica Franzin; Alice Cerato; Francesca Maletta; Mauro Giulio Papotti; Ezio Ghigo; Loredana Pagano; Mauro Maccario; Roberto Garberoglio
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-17       Impact factor: 5.555

Review 8.  Thyroid Radiofrequency Ablation: Updates on Innovative Devices and Techniques.

Authors:  Hye Sun Park; Jung Hwan Baek; Auh Whan Park; Sae Rom Chung; Young Jun Choi; Jeong Hyun Lee
Journal:  Korean J Radiol       Date:  2017-05-19       Impact factor: 3.500

9.  Clinical value of matrix metalloproteinase-2 and -9 in ultrasound-guided radiofrequency ablation treatment for papillary thyroid carcinoma.

Authors:  Qunyan Pan; Tao Yuan; Qian Ding
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

10.  2017 Thyroid Radiofrequency Ablation Guideline: Korean Society of Thyroid Radiology.

Authors:  Ji-Hoon Kim; Jung Hwan Baek; Hyun Kyung Lim; Hye Shin Ahn; Seon Mi Baek; Yoon Jung Choi; Young Jun Choi; Sae Rom Chung; Eun Ju Ha; Soo Yeon Hahn; So Lyung Jung; Dae Sik Kim; Soo Jin Kim; Yeo Koon Kim; Chang Yoon Lee; Jeong Hyun Lee; Kwang Hwi Lee; Young Hen Lee; Jeong Seon Park; Hyesun Park; Jung Hee Shin; Chong Hyun Suh; Jin Yong Sung; Jung Suk Sim; Inyoung Youn; Miyoung Choi; Dong Gyu Na
Journal:  Korean J Radiol       Date:  2018-06-14       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.